Evidence map›Paper›PMID 32977633›Full record

ReviewInternational journal of molecular sciences2020

Advances on Bone Substitutes through 3D Bioprinting.

Tullio Genova, Ilaria Roato, Massimo Carossa, Chiara Motta, Davide Cavagnetto, Federico Mussano

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tullio GenovaDepartment of Life Sciences and Systems Biology, University of Torino, via Accademia Albertina 13, 10123 Torino, Italy.ORCID 0000-0001-7824-8389
Ilaria RoatoDepartment of Surgical Sciences, University of Torino, via Nizza 230, 10126 Torino, Italy.
Massimo CarossaDepartment of Surgical Sciences, University of Torino, via Nizza 230, 10126 Torino, Italy.
Chiara MottaDepartment of Surgical Sciences, University of Torino, via Nizza 230, 10126 Torino, Italy.
Davide CavagnettoDepartment of Surgical Sciences, University of Torino, via Nizza 230, 10126 Torino, Italy.ORCID 0000-0001-8573-8327
Federico MussanoDepartment of Surgical Sciences, University of Torino, via Nizza 230, 10126 Torino, Italy.ORCID 0000-0001-5800-0749

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca L.232/2016
6 · The paper itself

Abstract

Reconstruction of bony defects is challenging when conventional grafting methods are used because of their intrinsic limitations (biological cost and/or biological properties). Bone regeneration techniques are rapidly evolving since the introduction of three-dimensional (3D) bioprinting. Bone tissue engineering is a branch of regenerative medicine that aims to find new solutions to treat bone defects, which can be repaired by 3D printed living tissues. Its aim is to overcome the limitations of conventional treatment options by improving osteoinduction and osteoconduction. Several techniques of bone bioprinting have been developed: inkjet, extrusion, and light-based 3D printers are nowadays available. Bioinks, i.e., the printing materials, also presented an evolution over the years. It seems that these new technologies might be extremely promising for bone regeneration. The purpose of the present review is to give a comprehensive summary of the past, the present, and future developments of bone bioprinting and bioinks, focusing the attention on crucial aspects of bone bioprinting such as selecting cell sources and attaining a viable vascularization within the newly printed bone. The main bioprinters currently available on the market and their characteristics have been taken into consideration, as well.

Indexed as

BioprintingBone RegenerationTissue EngineeringBone SubstitutesHumansPrinting, Three-DimensionalTissue ScaffoldsBone Substitutes3D bioprintingbiocompatible materialsbioprintingdentistryhydrogelsorthopedicsregenerative medicinetissue engineering

Identifiers

PMID32977633
PMCPMC7582371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.